Código QR (código de barras bidimensional)

Real‐world use of lecanemab: patient pathway findings from a US multicenter study

Abstract Introduction To ensure Alzheimer's disease‐modifying treatments can be initiated in diverse populations, efficient pathways to obtain timely diagnoses are required. Methods This interim sub‐analysis of a multicenter US study included cross‐sectional surveys and interviews with neurologists...

ver descrição completa

Na minha lista:
Principais autores: Michael Rosenbloom, Courtney Adams, Brooke Allen, Brent Berry, Christian Camargo, Gregory Cooper, Samuel Giles, Cara Leahy, Marwan Sabbagh, Martin Sadowski, Curtis Schreiber, Paul E. Schulz, Jose Soria, David Weisman, Feride Frech, Daryl Rhys Jones
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2026-04-01
coleção:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:
Alzheimer's disease (AD)
anti‐amyloid monoclonal antibodies
anti‐amyloid therapy (AAT)
blood‐based biomarker (BBM)
diagnosis
lecanemab
Acesso em linha:https://doi.org/10.1002/dad2.70376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados